Trial Profile
Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Mar 2024
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary)
- Indications Atopic dermatitis
- Focus Pharmacodynamics
- 06 Feb 2024 Planned primary completion date changed from 31 Dec 2023 to 30 Apr 2024.
- 25 Jan 2023 Planned End Date changed from 30 Jun 2023 to 30 Jun 2024.
- 25 Jan 2023 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2023.